Cargando…

DBS of the ANT for refractory epilepsy: A single center experience of seizure reduction, side effects and neuropsychological outcomes

OBJECTIVE: Evaluation of the antiseizure efficacy, side effects and neuropsychological effects of Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT). ANT-DBS is a treatment option for patients with difficult-to-treat epilepsy. Though several works outline the cognitive and/or...

Descripción completa

Detalles Bibliográficos
Autores principales: Olaciregui Dague, Karmele, Witt, Juri-Alexander, von Wrede, Randi, Helmstaedter, Christoph, Surges, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033684/
https://www.ncbi.nlm.nih.gov/pubmed/36970547
http://dx.doi.org/10.3389/fneur.2023.1106511
_version_ 1784911046511689728
author Olaciregui Dague, Karmele
Witt, Juri-Alexander
von Wrede, Randi
Helmstaedter, Christoph
Surges, Rainer
author_facet Olaciregui Dague, Karmele
Witt, Juri-Alexander
von Wrede, Randi
Helmstaedter, Christoph
Surges, Rainer
author_sort Olaciregui Dague, Karmele
collection PubMed
description OBJECTIVE: Evaluation of the antiseizure efficacy, side effects and neuropsychological effects of Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT). ANT-DBS is a treatment option for patients with difficult-to-treat epilepsy. Though several works outline the cognitive and/or mood effects of ANT-DBS for the treatment of epilepsy, data on the intersection between antiseizure efficacy, cognitive and undesired effects are scarce. METHODS: We retrospectively analyzed the data of our cohort of 13 patients. Post-implantation seizure frequencies were measured at 6 months, 12 months and last follow-up, as well as averaged throughout follow-up. These values were then compared with mean seizure frequencies in the 6 months before implantation. To address acute cognitive effects of DBS a baseline assessment was performed after implantation and before stimulation, and a follow-up assessment was conducted under DBS. The long-term effects of DBS on cognition were assessed by comparing the preoperative neuropsychological profile with a long-term follow-up under DBS. RESULTS: In the entire cohort, 54.5% of patients were responders, with an average seizure reduction of 73.6%. One of these patients achieved temporary seizure freedom and near-total seizure reduction during the entire follow-up. Seizure reduction of <50% was achieved in 3 patients. Non-responders suffered an average seizure increase of 27.3%. Eight of twenty-two active electrodes (36,4%) were off-target. Two of our patients had both electrodes implanted off-target. When removing these two patients from the analysis and averaging seizure frequency during the entire follow-up period, four patients (44.4%) were responders and three experienced a seizure reduction of <50%. Intolerable side effects arose in 5 patients, mostly psychiatric. Regarding acute cognitive effects of DBS, only one patient showed a significant decline in executive functions. Long-term neuropsychological effects included significant intraindividual changes in verbal learning and memory. Figural memory, attention and executive functions, confrontative naming and mental rotation were mostly unchanged, and improved in few cases. SIGNIFICANCE: In our cohort, more than half of patients were responders. Psychiatric side effects seem to have been more prevalent compared to other published cohorts. This may be partially explained by a relatively high occurrence of off-target electrodes.
format Online
Article
Text
id pubmed-10033684
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100336842023-03-24 DBS of the ANT for refractory epilepsy: A single center experience of seizure reduction, side effects and neuropsychological outcomes Olaciregui Dague, Karmele Witt, Juri-Alexander von Wrede, Randi Helmstaedter, Christoph Surges, Rainer Front Neurol Neurology OBJECTIVE: Evaluation of the antiseizure efficacy, side effects and neuropsychological effects of Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT). ANT-DBS is a treatment option for patients with difficult-to-treat epilepsy. Though several works outline the cognitive and/or mood effects of ANT-DBS for the treatment of epilepsy, data on the intersection between antiseizure efficacy, cognitive and undesired effects are scarce. METHODS: We retrospectively analyzed the data of our cohort of 13 patients. Post-implantation seizure frequencies were measured at 6 months, 12 months and last follow-up, as well as averaged throughout follow-up. These values were then compared with mean seizure frequencies in the 6 months before implantation. To address acute cognitive effects of DBS a baseline assessment was performed after implantation and before stimulation, and a follow-up assessment was conducted under DBS. The long-term effects of DBS on cognition were assessed by comparing the preoperative neuropsychological profile with a long-term follow-up under DBS. RESULTS: In the entire cohort, 54.5% of patients were responders, with an average seizure reduction of 73.6%. One of these patients achieved temporary seizure freedom and near-total seizure reduction during the entire follow-up. Seizure reduction of <50% was achieved in 3 patients. Non-responders suffered an average seizure increase of 27.3%. Eight of twenty-two active electrodes (36,4%) were off-target. Two of our patients had both electrodes implanted off-target. When removing these two patients from the analysis and averaging seizure frequency during the entire follow-up period, four patients (44.4%) were responders and three experienced a seizure reduction of <50%. Intolerable side effects arose in 5 patients, mostly psychiatric. Regarding acute cognitive effects of DBS, only one patient showed a significant decline in executive functions. Long-term neuropsychological effects included significant intraindividual changes in verbal learning and memory. Figural memory, attention and executive functions, confrontative naming and mental rotation were mostly unchanged, and improved in few cases. SIGNIFICANCE: In our cohort, more than half of patients were responders. Psychiatric side effects seem to have been more prevalent compared to other published cohorts. This may be partially explained by a relatively high occurrence of off-target electrodes. Frontiers Media S.A. 2023-03-09 /pmc/articles/PMC10033684/ /pubmed/36970547 http://dx.doi.org/10.3389/fneur.2023.1106511 Text en Copyright © 2023 Olaciregui Dague, Witt, von Wrede, Helmstaedter and Surges. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Olaciregui Dague, Karmele
Witt, Juri-Alexander
von Wrede, Randi
Helmstaedter, Christoph
Surges, Rainer
DBS of the ANT for refractory epilepsy: A single center experience of seizure reduction, side effects and neuropsychological outcomes
title DBS of the ANT for refractory epilepsy: A single center experience of seizure reduction, side effects and neuropsychological outcomes
title_full DBS of the ANT for refractory epilepsy: A single center experience of seizure reduction, side effects and neuropsychological outcomes
title_fullStr DBS of the ANT for refractory epilepsy: A single center experience of seizure reduction, side effects and neuropsychological outcomes
title_full_unstemmed DBS of the ANT for refractory epilepsy: A single center experience of seizure reduction, side effects and neuropsychological outcomes
title_short DBS of the ANT for refractory epilepsy: A single center experience of seizure reduction, side effects and neuropsychological outcomes
title_sort dbs of the ant for refractory epilepsy: a single center experience of seizure reduction, side effects and neuropsychological outcomes
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033684/
https://www.ncbi.nlm.nih.gov/pubmed/36970547
http://dx.doi.org/10.3389/fneur.2023.1106511
work_keys_str_mv AT olacireguidaguekarmele dbsoftheantforrefractoryepilepsyasinglecenterexperienceofseizurereductionsideeffectsandneuropsychologicaloutcomes
AT wittjurialexander dbsoftheantforrefractoryepilepsyasinglecenterexperienceofseizurereductionsideeffectsandneuropsychologicaloutcomes
AT vonwrederandi dbsoftheantforrefractoryepilepsyasinglecenterexperienceofseizurereductionsideeffectsandneuropsychologicaloutcomes
AT helmstaedterchristoph dbsoftheantforrefractoryepilepsyasinglecenterexperienceofseizurereductionsideeffectsandneuropsychologicaloutcomes
AT surgesrainer dbsoftheantforrefractoryepilepsyasinglecenterexperienceofseizurereductionsideeffectsandneuropsychologicaloutcomes